To study the response of atomoxetine (a drug used in Attention Deficit hyperactivity Disorder) after one week by using (EEG)electroencephalogram in children with (ADHD)attention deficit hyperactivity disorder
Not Applicable
- Conditions
- Health Condition 1: null- ADHD children
- Registration Number
- CTRI/2017/02/007888
- Lead Sponsor
- Govt Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
1. Children from 6 to 14 years of age with a DSM 5 diagnosis of mild/ moderate/ severe ADHD.
2. Children who are drug naive.
3. Children giving assent and their guardian giving written consent to participate in the study.
Exclusion Criteria
1.Children who are on medicines that may affect EEG changes.
2.Children with history of physical illness like heart disease, seizures, febrile convulsions etc., any co-morbid mental illness like- bipolar affective disorder, psychosis, pervasive developmental disorder, Oppositional Defiant Disorder, Conduct Disorder, substance abuse, anxiety, mental retardation or tic disorder and any organic condition.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The absolute and relative power estimates for the delta, theta, alpha, beta and gamma bands in Electroencephalogram will be recorded.Timepoint: electroencephalogram at 1 week
- Secondary Outcome Measures
Name Time Method ilTimepoint: N/A